Tikun Olam ("To heal the world") is a company that grows and supplies medical marijuana and is licensed and supervised by the Ministry of Health in Israel, the first of its kind in that country.

In view of the impressive results of laboratory tests, and with the rise in the number of permits issued by the Ministry of Health, it was decided to extend the company's growing license and relocate to the north of the country to increase plant growth and improve security.

In 2010 The Ministry of Health regulated the issue of medical marijuana in Israel, and for the first time allowed Tikun Olam to collect 360 NIS per month for the service.

In 2012 the company received a stamp of approval from the Standards Institute of Israel in the areas of growth, production, sale, and distribution of medical marijuana, as well as in patient care.

The company's breakthrough came in the middle of 2012 when it was able to develop a unique strain of medical marijuana that does not contain the psychoactive substance THC, producing no sense of intoxication, and yet had anti-inflammatory properties of the plant called cannabidiol, or CBD.

This achievement led to the Ministry of Information and Diaspora holding a press conference at the company's facilities for leading media outlets in Israel and abroad to report this breakthrough.